1GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality World- wide [M]. International Agency for Research on Cancer, 2010. Accessed at http://globocan, iarc. fr.
2Murakami T. Pathomorphological diagnosis. Definition and gross classification of early gastric cancer [J]. Gann Monogr Rese, 1971, 11: 53-55.
6Liu C, Zhang R, Lu Y, et al. Prognostic role of lymphatic vessel invasion in early gastric cancer: A retrospective study of 188 cases IJ]. Surg Oncol, 2010, 19(1): 4-10.
7Kashimura H, Ajioka Y, Watanabe H, et al. Risk factor for nodal micrometastasis of submucosal gastric carcinoma: assessment ofindications for endoscopic treatment [J]. Gastric Cancer, 1999, 2(1): 33-39.
9Sowa M, Kato Y, Nishimura M, et al. Surgical approach to early gastric cancer with lymph node metastasis [J]. World J Surg, 1989, 13(5): 630-635.
10Tong JH, Sun Z, Wang ZN, et al. Early gastric cancer with signet-ring cell histologic type: resk factors of lymph node metas- tasis and indications of endoscopic surgery [J]. Surgery, 2011,.
2Namikawa T, Kitagawa H, Okabayashi T, et al. Double tractreconstruction after distal gastrectomy for gastric cancer is effectivein reducing reflux esophagitis and remnant gastritis with duodenalpassage preservation [J]. Langenbecks Arch Surg, 2011, 396(6):760 -776.
3Fujimura T, Oyama K, Sasaki S, et al. Inflammation-relatedcarcinogenesis and prevention in esophageal adenocarcinoma usingrat duodenoesophageal reflux models [J]. Cancers ( Basel) ,2011,3(3):3206-3224.
4Fukuhara K,Osugi H,Takeda N,ef al. Reconstructive procedureafterdistal gastrectomy for gastric cancer that best preventsduodenenoesophageal reflux [ J]. World J Surg, 2002,26 (12) : 1452 -1457.
5Hirao M, Tsujinaka T, Imamura H, et al. Overweight is a risk factorfor surgical site infection following distal gastrectomy for gastriccancer [ J]. Gastric Cancer,2013 ,16(2) :239 -244.
6Ishikawa M, Kitayama J, Kaizaki S, et al. Prospective randomized trial comparing Billroth-I and Roux-en-Y procedures after distal gastrectomy for gastric cancer [ J]. World J Surg,2005,29 (11 ) : 1415 - 1420.
7Kojima K, Yamada H,Inokuchi Mal. A comparison of Houxen-Y and Billroth-I reconstruction after laparoscopy-assisted distalgastrectomy [J].;Ann Surg,2008,247(6) :962 -967.
8Haagenson Kelly K, Wu GS. The role of MAP kinases and MAP kinase phosphatase - 1 in resistance to breast cancer treatment[ J]. Cancer and Metastasis Reviews, 2010,9 : 143 - 149.
9Kovalenko PL, Kunovska L,Chen J, et al. Loss of MLK3 sig- naling impedes ulcer healing by modulating MAPK signaling in mouse intestinal mucosa[ J~. American Journal of Physiol- ogy Gastrointestinal & Liver Physiology ,2012,303 ( 8 ) : G95 ! - G960.
10Zhan Y, Chadee DN. Inhibition of Cdc42 - mediated activa- tion of mixed lineage kinase 3 by the tumor suppressor pro- tein merli [ J ]. Small Gtpases ,2010,1 ( 3 ) : 183 - 186.
